HR
Harsh Rathnam
About Harsh Rathnam
Data last updated:
Harsh Rathnam has 6 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Avance Phytotherapies Private Limited and Novelgenix Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹48.2 Lakh; the largest is Avance Phytotherapies Private Limited at ₹47.3 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Avance Phytotherapies Private Limited U73100GJ2004PTC044109 | Director | 11 Dec 2019 | 2004 | ₹47.3 Lakh (FY 2023) | Active |
 Novelgenix Therapeutics Private Limited U74140GJ2011PTC065969 | Director | 09 Jun 2022 | 2011 | ₹93,183 (FY 2025) | Active |
 Apiqule Pharmachem Llp AAZ-9994 | Designated Partner | 23 Dec 2021 | 2021 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Harsh Rathnam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harsh Rathnam
Harsh Rathnam has 6 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Avance Phytotherapies Private Limited and Novelgenix Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹48.2 Lakh; the largest is Avance Phytotherapies Private Limited at ₹47.3 Lakh (FY 2023).
Harsh Rathnam is associated with 3 companies as Director and Designated Partner, including Avance Phytotherapies Private Limited (₹47.3 Lakh), Novelgenix Therapeutics Private Limited (₹93,183), Apiqule Pharmachem Llp.
Harsh Rathnam has expertise in General Business.
Harsh Rathnam has 6 years in corporate governance.
By reported revenue, the largest current company of Harsh Rathnam is Avance Phytotherapies Private Limited, with revenue of ₹47.3 Lakh (FY 2023).
The 2 current companies of Harsh Rathnam that report revenue have a combined latest revenue of ₹48.2 Lakh.
Harsh Rathnam currently holds positions at 3 companies: Avance Phytotherapies Private Limited (₹47.3 Lakh), Novelgenix Therapeutics Private Limited (₹93,183), Apiqule Pharmachem Llp.